Skip to main content

Published locations for Oral Laquinimod Reduced MS Relapses by 23% in Phase III Study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Oral Laquinimod Reduced MS Relapses by 23% in Phase III Study

User login

  • Reset your password
  • /content/oral-laquinimod-reduced-ms-relapses-23-phase-iii-study
  • /neurology/article/48610/multiple-sclerosis/oral-laquinimod-reduced-ms-relapses-23-phase-iii-study
  • /clinicalneurologynews/article/48610/multiple-sclerosis/oral-laquinimod-reduced-ms-relapses-23-phase